Survival, morbidity, and quality of life in pulmonary arterial hypertension patients: a systematic review of outcomes reported by population-based observational studies
Stefan Reinders, Eva‑Maria Didden, Rose OngActelion Pharmaceuticals and Johnson and Johnson.Peru and Switzerland Respiratory ResearchRespir Res 2024; 25: DOI: 10.1186/s12931-024-02994-w AbstractBackground: Comprehensive summaries on real-world outcomes in pulmonary arterial hypertension (PAH)-a rare, incurable condition, are lacking. We conducted a systematic literature review to describe current survival, morbidity, and quality of life (QoL) outcomes in adult and pediatric […]